Argenx (NASDAQ: ARGX) has been upgraded to an "outperform" rating from "underperform" by Bernstein, with the price target revised sharply upwards to €755 from 1 ...
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company committed to discovering and developing ...
Here is a look at the NEET UG 2025 syllabus and answers to frequently asked questions regarding the Biology subject.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results